vs
Cohen & Co Inc.（COHN）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Cohen & Co Inc.的1.9倍（$197.9M vs $102.7M），Cohen & Co Inc.同比增速更快（454.1% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-2.5M），过去两年Cohen & Co Inc.的营收复合增速更高（135.3% vs 14.4%）
科恩父子公司是一家总部位于伦敦商业路的废金属贸易商，由乔治·亨利·科恩于1834年创立，最初名为乔治·科恩公司，1883年创始人之子迈克尔·科恩入职后更名为现名。一战结束后，公司拿下多份大型合同，负责处理包括40万吨烈性炸药及炮弹在内的剩余军火。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
COHN vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.9倍
$102.7M
营收增速更快
COHN
高出440.5%
13.6%
自由现金流更多
RGEN
多$20.0M
$-2.5M
两年增速更快
COHN
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $102.7M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 29.2% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 454.1% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.77 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COHNRGEN
| Q4 25 | $102.7M | $197.9M | ||
| Q3 25 | $84.2M | $188.8M | ||
| Q2 25 | $59.9M | $182.4M | ||
| Q1 25 | $28.7M | $169.2M | ||
| Q4 24 | $18.5M | $174.1M | ||
| Q3 24 | $31.7M | $154.9M | ||
| Q2 24 | $10.8M | $154.1M | ||
| Q1 24 | $18.6M | $151.3M |
净利润COHNRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $4.6M | $14.9M | ||
| Q2 25 | $1.4M | $14.9M | ||
| Q1 25 | $329.0K | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $2.1M | $-654.0K | ||
| Q2 24 | $-2.3M | $3.3M | ||
| Q1 24 | $2.0M | $2.1M |
毛利率COHNRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率COHNRGEN
| Q4 25 | 29.2% | 9.0% | ||
| Q3 25 | 25.8% | 8.9% | ||
| Q2 25 | 12.5% | 7.6% | ||
| Q1 25 | 0.4% | 3.9% | ||
| Q4 24 | -29.7% | -17.7% | ||
| Q3 24 | 22.8% | -5.1% | ||
| Q2 24 | -59.0% | 1.0% | ||
| Q1 24 | -18.2% | 1.3% |
净利率COHNRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 5.5% | 7.9% | ||
| Q2 25 | 2.4% | 8.2% | ||
| Q1 25 | 1.1% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 6.8% | -0.4% | ||
| Q2 24 | -21.8% | 2.2% | ||
| Q1 24 | 10.9% | 1.4% |
每股收益（稀释后）COHNRGEN
| Q4 25 | $0.77 | $0.24 | ||
| Q3 25 | $2.58 | $0.26 | ||
| Q2 25 | $0.81 | $0.26 | ||
| Q1 25 | $0.19 | $0.10 | ||
| Q4 24 | $-1.20 | $-0.55 | ||
| Q3 24 | $1.31 | $-0.01 | ||
| Q2 24 | $-1.47 | $0.06 | ||
| Q1 24 | $1.28 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $56.8M | $767.6M |
| 总债务越低越好 | $32.9M | $542.2M |
| 股东权益账面价值 | $51.1M | $2.1B |
| 总资产 | $700.6M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.64× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资COHNRGEN
| Q4 25 | $56.8M | $767.6M | ||
| Q3 25 | $54.7M | $748.7M | ||
| Q2 25 | $26.0M | $708.9M | ||
| Q1 25 | $14.0M | $697.2M | ||
| Q4 24 | $19.6M | $757.4M | ||
| Q3 24 | $14.3M | $784.0M | ||
| Q2 24 | $9.6M | $809.1M | ||
| Q1 24 | $11.8M | $780.6M |
总债务COHNRGEN
| Q4 25 | $32.9M | $542.2M | ||
| Q3 25 | $32.7M | $537.9M | ||
| Q2 25 | $32.6M | — | ||
| Q1 25 | $35.0M | — | ||
| Q4 24 | $34.9M | $525.6M | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $29.7M | — | ||
| Q1 24 | $29.7M | — |
股东权益COHNRGEN
| Q4 25 | $51.1M | $2.1B | ||
| Q3 25 | $47.8M | $2.1B | ||
| Q2 25 | $43.4M | $2.1B | ||
| Q1 25 | $42.0M | $2.0B | ||
| Q4 24 | $41.7M | $2.0B | ||
| Q3 24 | $43.8M | $2.0B | ||
| Q2 24 | $41.7M | $2.0B | ||
| Q1 24 | $43.8M | $2.0B |
总资产COHNRGEN
| Q4 25 | $700.6M | $2.9B | ||
| Q3 25 | $773.9M | $2.9B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $978.0M | $2.9B | ||
| Q4 24 | $971.1M | $2.8B | ||
| Q3 24 | $818.0M | $2.8B | ||
| Q2 24 | $826.0M | $2.9B | ||
| Q1 24 | $1.1B | $2.8B |
负债/权益比COHNRGEN
| Q4 25 | 0.64× | 0.26× | ||
| Q3 25 | 0.68× | 0.26× | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 0.83× | — | ||
| Q4 24 | 0.84× | 0.27× | ||
| Q3 24 | 0.80× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $17.6M |
| 自由现金流率自由现金流/营收 | -2.4% | 8.9% |
| 资本支出强度资本支出/营收 | 0.4% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $26.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流COHNRGEN
| Q4 25 | $-2.1M | $25.7M | ||
| Q3 25 | $22.4M | $48.1M | ||
| Q2 25 | $13.3M | $28.6M | ||
| Q1 25 | $-6.4M | $15.0M | ||
| Q4 24 | $4.4M | $39.2M | ||
| Q3 24 | $4.1M | $49.3M | ||
| Q2 24 | $-4.2M | $42.2M | ||
| Q1 24 | $5.1M | $44.7M |
自由现金流COHNRGEN
| Q4 25 | $-2.5M | $17.6M | ||
| Q3 25 | $22.2M | $43.4M | ||
| Q2 25 | $12.9M | $21.5M | ||
| Q1 25 | $-6.5M | $11.4M | ||
| Q4 24 | $4.0M | $33.6M | ||
| Q3 24 | $3.8M | $42.3M | ||
| Q2 24 | $-4.6M | $37.4M | ||
| Q1 24 | $5.0M | $36.4M |
自由现金流率COHNRGEN
| Q4 25 | -2.4% | 8.9% | ||
| Q3 25 | 26.3% | 23.0% | ||
| Q2 25 | 21.6% | 11.8% | ||
| Q1 25 | -22.7% | 6.8% | ||
| Q4 24 | 21.4% | 19.3% | ||
| Q3 24 | 12.0% | 27.3% | ||
| Q2 24 | -42.4% | 24.3% | ||
| Q1 24 | 27.1% | 24.0% |
资本支出强度COHNRGEN
| Q4 25 | 0.4% | 4.1% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 0.7% | 3.9% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 2.5% | 3.2% | ||
| Q3 24 | 1.0% | 4.5% | ||
| Q2 24 | 3.5% | 3.1% | ||
| Q1 24 | 0.5% | 5.5% |
现金转化率COHNRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 4.88× | 3.23× | ||
| Q2 25 | 9.48× | 1.92× | ||
| Q1 25 | -19.37× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.91× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 2.54× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COHN
| Capital Markets | $68.5M | 67% |
| Other | $25.7M | 25% |
| Gestational Repo Business | $5.6M | 5% |
| Asset Management Segment | $2.9M | 3% |
RGEN
暂无分部数据
